Tag: lisocabtagene maraleucel

Bristol Myers Squibb gets FDA priority review for Breyanzi sBLA

pallavi123- February 19, 2022

Bristol Myers Squibb (BMS) has secured priority review from the US Food and Drug Administration (FDA) for its supplemental biologics license application (sBLA) for Breyanzi ... Read More